BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Porcel JM. Distinguishing complicated from uncomplicated parapneumonic effusions. Curr Opin Pulm Med 2015;21:346-51. [PMID: 26016577 DOI: 10.1097/MCP.0000000000000164] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Sundaralingam A, Banka R, Rahman NM. Management of Pleural Infection. Pulm Ther 2021;7:59-74. [PMID: 33296057 DOI: 10.1007/s41030-020-00140-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Porcel J, Valencia H, Bielsa S. Factors influencing pleural drainage in parapneumonic effusions. Revista Clínica Española (English Edition) 2016;216:361-6. [DOI: 10.1016/j.rceng.2016.04.005] [Reference Citation Analysis]
3 Jany B, Welte T. Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment. Dtsch Arztebl Int 2019;116:377-86. [PMID: 31315808 DOI: 10.3238/arztebl.2019.0377] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
4 Li D, Shen Y, Qin J, Wan C, Zeng N, Chen L, Dong Y. Diagnostic performance of C-reactive protein for parapneumonic pleural effusion: a meta-analysis. Ann Transl Med 2019;7:1. [PMID: 30788348 DOI: 10.21037/atm.2018.11.44] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
5 Jiang C, Xie M, Cervellione K, Thurm C. Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study. BMC Res Notes 2020;13:368. [PMID: 32746902 DOI: 10.1186/s13104-020-05210-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Kogan Y, Sabo E, Odeh M. Diagnostic Value of C-Reactive Protein in Discrimination between Uncomplicated and Complicated Parapneumonic Effusion. Diagnostics (Basel) 2020;10:E829. [PMID: 33076437 DOI: 10.3390/diagnostics10100829] [Reference Citation Analysis]
7 Gasparini S, Bonifazi M. Pleural diseases. Curr Opin Pulm Med 2017;23:269-74. [PMID: 28257316 DOI: 10.1097/MCP.0000000000000374] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Lin L, Li S, Xiong Q, Wang H. A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion. BMC Pulm Med 2021;21:95. [PMID: 33740937 DOI: 10.1186/s12890-021-01459-w] [Reference Citation Analysis]
9 Iliopoulou M, Skouras V, Psaroudaki Z, Makarona M, Vogiatzakis E, Tsorlini E, Katsifa E, Spyratos D, Siopi D, Kotsiou O, Xitsas S, Martsoukou M, Sigala I, Kalomenidis I. Bacteriology, antibiotic resistance and risk stratification of patients with culture-positive, community-acquired pleural infection. J Thorac Dis 2021;13:521-32. [PMID: 33717525 DOI: 10.21037/jtd-20-2786] [Reference Citation Analysis]